- ISIN
- US26622P1075
- CUSIP
- 26622P107
- Sector
- Healthcare
- Industry
- Health Information Services
- IPO Date
- Jun 24, 2021
Highlights
- Market Cap
- $3.91B
- Enterprise Value
- $3.70B
- EPS (TTM)
- $0.99
- PE Ratio
- 21.15
- PEG Ratio
- 1.80
- Total Revenue (TTM)
- $644.86M
- Gross Profit (TTM)
- $574.54M
- EBITDA (TTM)
- $245.76M
- Year Range
- $17.15 - $76.51
- Target Price
- $41.86
- ROA (TTM)
- 17.45%
- ROE (TTM)
- 20.62%
- Avg. Volume (1M)
- 3M
- Avg. Volume Value (1M)
- $63.08M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
DOCS Performance Chart
Doximity, Inc. (DOCS) is down 52.8% since the beginning of the year. At $21 per share, DOCS is trading 72.7% below its 52-week high of $77. Investors who bought $1,000 worth of DOCS shares 5 years ago would now be looking at an investment worth $338.
Loading charts...
Compare this symbol against anything
Returns By Period
Doximity, Inc. (DOCS) has returned -52.78% so far this year and -63.53% over the past 12 months.
Doximity, Inc.
- 1D
- -1.55%
- 1M
- -4.35%
- 6M
- -44.20%
- YTD
- -52.78%
- 1Y
- -63.53%
- 3Y*
- -15.61%
- 5Y*
- -19.51%
- 10Y*
- —
- ALL TIME*
- -12.44%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
DOCS Monthly Returns History
Based on dividend-adjusted daily data since Jun 24, 2021, DOCS's average daily return is +0.04%, while the average monthly return is +0.34%. At this rate, an investment would double in approximately 17.0 years.
Historically, 44% of months were positive and 56% were negative. The best month was Aug 2021 with a return of +48.6%, while the worst month was Feb 2026 at -34.5%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.
On a daily basis, DOCS closed higher 50% of trading days. The best single day was Aug 9, 2024 with a return of +38.7%, while the worst single day was May 14, 2026 at -23.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -15.38% | -34.53% | -5.01% | 4.89% | -12.44% | -3.08% | 0.82% | -52.78% | |||||
| 2025 | 10.69% | 19.29% | -17.69% | -1.98% | -8.42% | 17.76% | -4.22% | 15.64% | 7.67% | -9.77% | -22.06% | -13.92% | -17.06% |
| 2024 | -3.89% | 4.75% | -4.68% | -9.74% | 14.16% | 0.87% | 0.11% | 31.36% | 18.46% | -4.20% | 26.98% | 0.74% | 90.41% |
| 2023 | 5.10% | -4.65% | -3.72% | 13.50% | -16.54% | 10.92% | 5.03% | -33.28% | -10.99% | -3.72% | 13.80% | 20.60% | -16.45% |
| 2022 | -9.10% | 34.63% | -15.09% | -23.46% | -12.24% | -0.49% | 21.54% | -21.57% | -8.95% | -12.41% | 28.41% | -1.27% | -33.05% |
| 2021 | 41.37% | 6.36% | 48.63% | -12.28% | -13.90% | -2.63% | -25.90% | 21.76% |
Benchmark Metrics
Doximity, Inc. has an annualized alpha of -7.76%, beta of 1.41, and R2 of 0.12 versus S&P 500 Index. Calculated based on daily prices since June 24, 2021.
- This stock participated in 179.00% of S&P 500 Index downside but only 90.55% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.12 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -7.76%
- Beta
- 1.41
- R²
- 0.12
- Upside Capture
- 90.55%
- Downside Capture
- 179.00%
Return for Risk
Risk / Return Rank
DOCS ranks 6 for risk / return — above 6% of stocks peers on PortfoliosLab. Its historical combined result is below most peers; review the five component ranks for context.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Doximity, Inc. (DOCS) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DOCS | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.60 | ||
| Sortino ratioReturn per unit of downside risk | -3.90 | ||
| Omega ratioGain probability vs. loss probability | 0.73 | 1.25 | -0.53 |
| Calmar ratioReturn relative to maximum drawdown | -0.85 | 2.00 | -2.85 |
| Martin ratioReturn relative to average drawdown | -1.23 | 8.49 | -9.72 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Doximity, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Doximity, Inc. was 82.35%, occurring on May 14, 2026. The portfolio has not yet recovered.
The current Doximity, Inc. drawdown is 79.50%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-82.35%May 2026 | 4y 8mo | — | 4y 10moSep 2021 - now | — |
-21.26%Aug 2021 | 10d | 5d | 15dJul 2021 - Aug 2021 | — |
-19.76%Jul 2021 | 7d | 16d | 23dJun 2021 - Jul 2021 | — |
-12.81%Aug 2021 | 1d | 7d | 7dAug 2021 - Sep 2021 | — |
-7.11%Aug 2021 | 2d | 4d | 6dAug 2021 - Aug 2021 | — |
Drawdown Indicators
| DOCS | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.35% | -56.78% | -25.57% |
Max Drawdown (1Y)Largest decline over 1 year | -76.03% | -9.10% | -66.93% |
Max Drawdown (3Y)Largest decline over 3 years | -78.34% | -18.90% | -59.44% |
Max Drawdown (5Y)Largest decline over 5 years | -82.35% | -25.43% | -56.92% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -79.50% | -1.58% | -77.92% |
Average DrawdownAverage peak-to-trough decline | -57.75% | -10.70% | -47.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 52.35% | 2.14% | +50.21% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Doximity, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Doximity, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for DOCS, comparing it with other companies in the Health Information Services industry. Currently, DOCS has a P/E ratio of 21.2. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for DOCS compared to other companies in the Health Information Services industry. DOCS currently has a PEG ratio of 1.8. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for DOCS relative to other companies in the Health Information Services industry. Currently, DOCS has a P/S ratio of 6.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for DOCS in comparison with other companies in the Health Information Services industry. Currently, DOCS has a P/B value of 4.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with DOCS
Add Doximity, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with DOCS